logo1
Galapagos Genomics Receives Grants to Expand Functional Genomics Platform
June 20, 2002 07:30 ET | Galapagos NV
Mechelen, Belgium, June 20, 2002 -- Galapagos Genomics, the Belgian/Dutch functional genomics company, announced today that it has been awarded technology development grants in Belgium and the...
logo1
Robin Brown Joins Galapagos Genomics As Chief Scientific Officer
May 21, 2002 07:30 ET | Galapagos NV
Mechelen, Belgium -- May 21, 2002 - Galapagos Genomics NV announced today that Robin Brown has been appointed Chief Scientific Officer (CSO). Dr. Brown will be responsible for directing the research...
logo1
Galapagos Genomics Raises Euro21.4 Million in Private Placement
March 05, 2002 07:30 ET | Galapagos NV
Mechelen, Belgium, March 5, 2002 -- Galapagos Genomics, the Belgian/Dutch functional genomics company, today announced the completion of a Euro21.4 million private placement. This first round of...
logo1
Galapagos Genomics and Exelixis Collaborate in Gene Function Analysis
January 23, 2002 08:00 ET | Galapagos NV
Mechelen, Belgium, January 23, 2002 -- Galapagos Genomics NV, the Belgian functional genomics company, today announced a research collaboration with Exelixis, Inc., for the use of Galapagos'...
logo1
Galapagos Genomics Receives US Patent for its PhenoSelect(TM) Platform
January 23, 2002 08:00 ET | Galapagos NV
Mechelen, Belgium, January 23, 2002 -- Galapagos Genomics NV, the Belgian functional genomics company, today announced that it has been awarded US Patent No. 6,340,595 entitled "High Throughput...
logo1
Galapagos Genomics and Euroscreen enter into a Collaboration on G-Protein Coupled Receptors
December 10, 2001 07:30 ET | Galapagos NV
Under the terms of the agreement, Galapagos will supply Euroscreen with an arrayed collection of secreted proteins and peptides ("peptide library") from human cells infected with the Galapagos...